ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (OTC BB:RXHN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, today announced that Ted Jeong, Chief Financial Officer of the Company, will be presenting an overview of Rexahn Pharmaceuticals at The 2007 Robins Healthcare Investor Conference on Thursday, October 4, 2007 at the University Club in New York City.
